未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB-D melanoma: a phase 1/2 trial 新辅助抗PD-1单药或联合抗TIGIT或溶瘤病毒在可切除的III B-D期黑色素瘤中的应用：一项I/II期临床试验 Dummer, Reinhard; Robert, Caroline; Scolyer, Richard A.; Taube, Janis M.; Tetzlaff, Michael T.; Menzies, Alexander M.; Hill, Andrew; Grob, Jean-Jacques; Portnoy, David C.; Lebbe, Celeste; Khattak, Muhammad A.; Cohen, Jonathan; Bar-Sela, Gil; Mehmi, Inderjit; Shapira-Frommer, Ronnie; Meyer, Nicolas; Webber, Andrea L.; Ren, Yixin; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Long, Georgina V. 分享 收藏
ER+HER2-early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes Goldvaser, Hadar; Yerushalmi, Rinat; Mutai, Raz; Kuchuk, Iryna; Toker, Margarita; Paluch-Shimon, Shani; Drumea, Karen; Evron, Ella; Sonnenblick, Amir; Gal-Yam, Einav; Sela, Gil Bar-; Shai, Ayelet; Merose, Rotem; Bareket-Samish, Avital; Soussan-Gutman, Lior; Stemmer, Salomon M. 分享 收藏
分享 收藏
KEYMAKER-U02 substudy 02C: Neoadjuvant pembrolizumab (pembro) and investigational agents followed by adjuvant pembro for stage IIIB-D melanoma KEYMAKER-U02 子研究 02C：新辅助培美曲塞（pembro）和研究性药物，随后进行辅助培美曲塞治疗用于IIIB-D期黑色素瘤 Long, G. V.; Robert, C.; Hill, A. G.; Marqueste, C. Gaudy; Portnoy, D.; Shapira, R.; Cohen, J. E.; Khattak, M. A.; Lebbe, C.; Menzies, A. M.; Markel, G.; Bar-Sela, G.; Sharfman, W. H.; Pages, C.; Hamid, O.; Mehnert, J. M.; Jing, N.; Kalabis, M.; Krepler, C.; Dummer, R. 分享 收藏
KEYMAKER 02B: A randomized trial of pembrolizumab (pembro) alone or with investigational agents as first-line treatment for advanced melanoma KEYMAKER 02B：一项关于帕博利珠单抗（pembro）单药或联合试验性药物作为晚期黑色素瘤一线治疗的随机试验 Dummer, R.; Shapira, R.; Pigozzo, J.; Ascierto, P. A.; Marqueste, C. Gaudy; Portnoy, D.; Del Vecchio, M.; Bar-Sela, G.; Cohen, J. E.; Di Giacomo, A. M.; Ribas, A.; Dutriaux, C.; Belli, C.; Cohen, G.; Dokhan, R.; Jing, N.; Lal, R.; Krepler, C.; Long, G. V. 分享 收藏
Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world data Brenner, B.; Shulman, K.; Hubert, A.; Man, S.; Geva, R.; Ben-Aharon, I.; Fennig, S.; Mishaeli, M.; Yarom, N.; Bar-Sela, G.; Brenner, R.; Shai, A.; Baehner, F. L.; Russell, C.; Soussan-Gutman, L.; Voet, H.; Bareket-Samish, A.; Liebermann, N. 分享 收藏
The impact of Human Epidermal growth factor Receptor 2 (HER2) expression by RT-PCR on tumor characteristics and outcome in estrogen receptor (ER) positive, HER2 negative early-stage breast cancer Goldvaser, Hadar; Mutai, Raz; Stemmer, Salomon; Kuchuk, Iryna; Tokar, Margarita; Paluch-Shimon, Shani; Yerushalmi, Rinat; Drumea, Karen; Evron, Ella; Sonnenblick, Amir; Gal-Yam, Einav; Bar Sela, Gil; Shai, Ayelet; Merose, Rotem; Bareket-Samish, Avital; Soussan-Gutman, Lior 分享 收藏
分享 收藏
Nuclear localization of heparanase 2 (Hpa2) attenuates breast carcinoma growth and metastasis Hilwi, Maram; Shulman, Katherina; Naroditsky, Inna; Feld, Sari; Gross-Cohen, Miriam; Boyango, Ilanit; Soboh, Soaad; Vornicova, Olga; Farhoud, Malik; Singh, Preeti; Bar-Sela, Gil; Goldberg, Hadassah; Goette, Martin; Sharrocks, Andrew D.; Li, Yaoyong; Sanderson, Ralph D.; Ilan, Neta; Vlodavsky, Israel 分享 收藏
Challenges in Implementing Guideline on Integrative Oncology and Pain: The Israeli Perspective Ben-Arye, Eran; Mao, Jun; Bruera, Eduardo; Samuels, Noah; Keshet, Yael; Lee, Richard T.; Ben-Yehuda, Dina; Eisenberg, Elon; Bar-Sela, Gil; Shvartzman, Pesach; Balneaves, Lynda G.; Shani, Michal; Ellis, Martin; Tripathy, Debu; Ash, Shifra; Elis, Avishay; Vaknin, Zvi; Ofir, Ruth; Schiff, Elad 分享 收藏
分享 收藏
Linkage between Psychological Factors and Response to Immune Checkpoint Inhibitor Therapy: A Preliminary Study Cohen, Miri; Shamay, Yosi; Czamanski-Cohen, Johanna; Shulman, Katerina; Keren Rosenberg, Shoshana; Abu-Amna, Mahmoud; Turgeman, Ilit; Merkin Livshits, Ludmila; Birenboim, Revital; Dines, Monica; Bar-Sela, Gil 分享 收藏
Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes-exploratory analysis of the Clalit registry Shachar, Shlomit S.; Leviov, Michelle; Yerushalmi, Rinat; Drumea, Karen; Tokar, Margarita; Soussan-Gutman, Lior; Bareket-Samish, Avital; Sonnenblick, Amir; Ben-Baruch, Noa; Evron, Ella; Gal-Yam, Einav Nili; Paluch-Shimon, Shani; Bar-Sela, Gil; Goldvaser, Hadar; Stemmer, Salomon M. 分享 收藏
KEYMAKER-U02 substudy 02C: neoadjuvant pembrolizumab (pembro) plus vibostolimab (vibo) or gebasaxturev (geba) or pembro alone followed by adjuvant pembro for stage IIIB-D melanoma Dummer, Reinhard; Robert, Caroline; Scolyer, Richard A.; Taube, Janis M.; Tetzlaff, Michael T.; Hill, Andrew; Grob, Jean-Jacques; Portnoy, David C.; Lebbe, Celeste; Khattak, Muhammad A.; Cohen, Jonathan; Bar-Sela, Gil; Mehmi, Inderjit; Frommer, Ronnie Shapira; Meyer, Nicolas; Ren, Yixin; Fukunaga-Kalabis, Mizuho; Krepler, Clemens; Long, Georgina V. 分享 收藏
分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
